v3.26.3
Net Income (Loss) per Share - Schedule of Error Corrections and Prior Period Adjustments (Details) - $ / shares
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Anti-dilutive securities              
Weighted average number of shares outstanding - basic (Note 13) (in shares) 29,247,673 28,508,089 29,142,570 28,276,865 28,409,706 26,908,070 21,562,581
Weighted average number of shares outstanding - diluted (Note 13) (in shares) 30,313,137 28,508,089 29,142,570 28,276,865 28,409,706 26,908,070 21,562,581
Net income (loss) per common, Series A preferred, and Series B preferred share - basic (in dollars per share) $ 1.90 $ (4.01) $ (3.32) $ (8.12) $ (10.15) $ (17.31) $ (17.33)
Net income (loss) per common, Series A preferred, and Series B preferred share - diluted (in dollars per share) $ 1.83 $ (4.01) $ (3.32) $ (8.12) $ (10.15) $ (17.31) $ (17.33)
As Reported              
Anti-dilutive securities              
Weighted average number of shares outstanding - basic (Note 13) (in shares)   22,482,502   22,261,718 22,434,310 21,272,962 18,687,774
Weighted average number of shares outstanding - diluted (Note 13) (in shares)   22,482,502   22,261,718 22,434,310 21,272,962 18,687,774
Net income (loss) per common, Series A preferred, and Series B preferred share - basic (in dollars per share)   $ (5.08)   $ (10.32) $ (12.85) $ (21.90) $ (19.99)
Net income (loss) per common, Series A preferred, and Series B preferred share - diluted (in dollars per share)   $ (5.08)   $ (10.32) $ (12.85) $ (21.90) $ (19.99)